Market Research Logo

Mobidiag Ltd - Product Pipeline Analysis, 2018 Update

Summary

Mobidiag Ltd (Mobidiag) is a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products include Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screening of gastrointestinal pathogens and antibiotic resistances. Mobidiag's Prove-it products include prove-it sepsis, prove-it bone and joint, and prove-it herpes for the detection and analysis of the microarrays. The company's target therapy areas comprise in vitro diagnostics, gastrointestinal infections, and other infectious diseases. It serves customers across France. The company has operations in Finland, Sweden, the UK and France. Mobidiag is headquartered in Espoo, Finland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Mobidiag Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


  • Mobidiag Ltd Company Overview
    • Mobidiag Ltd Company Snapshot
    • Mobidiag Ltd Pipeline Products and Ongoing Clinical Trials Overview
      • Table Mobidiag Ltd Pipeline Products and Ongoing Clinical Trials Overview
      • Table Mobidiag Ltd Pipeline Products by Equipment Type
      • Table Figure 1: Mobidiag Ltd Pipeline Products by Equipment Type
      • Table Mobidiag Ltd Pipeline Products by Indication
  • Mobidiag Ltd – Pipeline Analysis Overview
    • Mobidiag Ltd - Key Facts
      • Table Mobidiag Ltd, Key Facts
    • Mobidiag Ltd - Major Products and Services
      • Table Mobidiag Ltd, Major Products and Services
    • Mobidiag Ltd Pipeline Products by Development Stage
      • Table Figure 2: Mobidiag Ltd Pipeline Products by Development Stage
      • Table Mobidiag Ltd Number of Pipeline Products by Development Stage
      • Table Mobidiag Ltd Pipeline Products Summary by Development Stage
  • Mobidiag Ltd Pipeline Products Overview
    • GeneSpress
      • GeneSpress Product Overview
        • Table GeneSpress - Product Status
        • Table GeneSpress - Product Description
    • Novodiag System - Bloodstream Infections
      • Novodiag System - Bloodstream Infections Product Overview
        • Table Novodiag System - Bloodstream Infections - Product Status
        • Table Novodiag System - Bloodstream Infections - Product Description
    • Novodiag System - Central Nervous System Infections
      • Novodiag System - Central Nervous System Infections Product Overview
        • Table Novodiag System - Central Nervous System Infections - Product Status
        • Table Novodiag System - Central Nervous System Infections - Product Description
    • Novodiag System - Gastrointestinal Infections
      • Novodiag System - Gastrointestinal Infections Product Overview
        • Table Novodiag System - Gastrointestinal Infections - Product Status
        • Table Novodiag System - Gastrointestinal Infections - Product Description
    • Novodiag System - Hospital Acquired Infections
      • Novodiag System - Hospital Acquired Infections Product Overview
        • Table Novodiag System - Hospital Acquired Infections - Product Status
        • Table Novodiag System - Hospital Acquired Infections - Product Description
    • Novodiag System - Respiratory Infections
      • Novodiag System - Respiratory Infections Product Overview
        • Table Novodiag System - Respiratory Infections - Product Status
        • Table Novodiag System - Respiratory Infections - Product Description
    • Novodiag System - Skin And Soft Tissue Infections
      • Novodiag System - Skin And Soft Tissue Infections Product Overview
        • Table Novodiag System - Skin And Soft Tissue Infections - Product Status
        • Table Novodiag System - Skin And Soft Tissue Infections - Product Description
  • Mobidiag Ltd - Key Competitors
  • Mobidiag Ltd - Key Employees
    • Table Mobidiag Ltd, Key Employees
  • Mobidiag Ltd - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
      • Table Mobidiag Ltd, Other Locations
  • Recent Developments
    • Mobidiag Ltd, Recent Developments
      • May 29, 2018: Mobidiag Secures Additional Funding from Business Finland for Development of Rapid Sepsis Diagnostics Test Directly from Blood
      • Apr 19, 2018: Mobidiag Announces CE-IVD Marking of Amplidiag CarbaR+MCR, a multiplex qPCR test for detection of antibiotic resistant bacteria
      • Apr 17, 2018: Launch of Novodiag Bacterial GE+, a new diagnostic test for on-demand detection of bacterial pathogens
      • Mar 05, 2018: Mobidiag Implements High Throughput Manufacturing Lines to Answer Growing Needs for Novodiag Cartridges
      • Mar 05, 2018: Ginolis Provides Mobidiag High Throughput Manufacturing Lines for Growing Needs of Novodiag Cartridges
      • Jan 03, 2018: Mobidiag launches Novodiag, a new diagnostic solution for infectious diseases
      • Jun 26, 2017: Mobidiag Announces Release of Amplidiag Viral GE, a Multiplex PCR Test to Detect Gastrointestinal Viruses Directly from Stool Samples
      • May 30, 2017: Mobidiag Extends Distribution Agreement with PerkinElmer to Offer Amplidiag Diagnostics Products in African Countries and Israel
      • Mar 27, 2017: Mobidiag Pursues its Growth with New Offices in United Kingdom and Appoints Stuart Cranmer as Managing Director
      • Mar 15, 2017: Mobidiag Granted Patents Covering the Method and related Kit for Detecting Antibiotic Resistant Bacteria
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report